Patent · US Active

3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors

US10087176B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Gabriele Amari · Parma, IT
Elisabetta Armani · Parma, IT
Mauro Riccaboni · Parma, IT
Andrea Rizzi · Parma, IT
Charles Baker-Glenn · Saffron Walden, GB
Wesley Blackaby · Cambridge, GB
Hervé Van De Poël · Saffron Walden, GB
Ben Whittaker · Saffron Walden, GB

Key dates

Filing date	Jun 4, 2014
Grant date	Oct 2, 2018
Priority date	—
Expiry date	Jun 4, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D453/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to novel 3,5-dichloro,4-(3,4-(cyclo-) alkoxyphenyl)-2-carbonyloxy)ethyl)pyridine compounds which are inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.